The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

生物制药面临的CMC合规性挑战

制药工程

售   价:
2033.00
发货周期:预计8-10周发货
作      者
出  版 社
出版时间
2013年05月07日
装      帧
精装
ISBN
9781461469155
复制
页      码
338
语      种
英文
版      次
2
综合评分
暂无评分
我 要 买
- +
库存 18 本
  • 图书详情
  • 目次
  • 买家须知
  • 书评(0)
  • 权威书评(0)
图书简介
This book highlights the challenges facing quality assurance/quality control (QA/QC) in today’s biopharmaceutical environment and presents the strategic importance and value generated by QA/QC for their involvement in control of manufacturing. It will put into perspective the need for a graded approach to QA/QC from early clinical trials through market approval. Since the first edition published in 2004, there have been more than 50 new regulatory guidances released by the Food and Drug Administration (FDA), European Medicines Agency (EMA) and ICH that affect the CMC regulatory compliance of biopharmaceuticals; also the application of biosimilars has been developed in Europe and is under development in the USA. The revised update will be broadened to include not only biopharmaceuticals (biotech drugs) but also other biologics (vaccines, cell therapy, plasma-derived proteins, etc.)
本书暂无推荐
本书暂无推荐
看了又看
  • 上一个
  • 下一个